When was Antares Pharma founded?

Antares Pharma was founded in 2000 and raised its 1st funding round 7 years after it was founded.

Where is Antares Pharma located?

Antares Pharma is headquartered in Ewing, United States.

How many employees does Antares Pharma have?

As of May 31, 2026, the latest employee count at Antares Pharma is 55.

Is Antares Pharma a funded company?

Antares Pharma is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Mar 19, 2007.

When was the latest funding round of Antares Pharma?

Antares Pharma's latest funding was a $***** Post IPO round on Mar 06, 2018, with participation from 1 investor.

What is the annual revenue of Antares Pharma?

Annual revenue of Antares Pharma is between $100M and $500M as on Dec 31, 2021

Antares Pharma - 2026 Company Profile, Funding & Financials

Antares Pharma is an acquired company based in Ewing (United States), founded in 2000. It operates as a Reformulates existing drugs using pen injectors. Antares Pharma has raised an undisclosed amount in funding.

Company Details

Antares Pharma specializes in reformulating existing drugs using pen injectors. Its proprietary platform VIBEX is a pre-filled pen injector that can be used to deliver drugs intradermally, subcutaneously or intramuscularly. It partners with several other pharma companies to reformulate their drugs. Its product pipeline includes pens for human growth hormone (Ferring), estradiol (Meda), Gelnique(Actavis) and methotrexate.

Key Metrics

Founded Year

2000

Location

Ewing, United States

Stage

Acquired

Latest Funding Round

Post IPO, Mar 06, 2018, $*****

Investors

Hercules Capital & 3 more

Annual Revenue

$100M - $500M as on Dec 31, 2021

Employee Count

55 as on May 31, 2026

Exit Details

Acquired by Halozyme (Apr 13, 2022)

View Antares Pharma's full profile

Antares Pharma is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Antares Pharma, Inc. CIN: 1016169 , United States, Active	Jun 23, 1996	$100M - $500M (As on Dec 31, 2021)	-	-

Antares Pharma got acquired by Halozyme on Apr 13, 2022.

Click here to take a look at Antares Pharma's acquisition in detail

Antares Pharma has raised funding over 4 rounds. Its first funding round was on Mar 19, 2007. Its latest funding round was a Post IPO round on Mar 06, 2018 for $*****. 1 investor participated in its latest round. Antares Pharma has 4 institutional investors.

Here is the list of recent funding rounds of Antares Pharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 06, 2018	2608777	Post IPO	5590332	4859195	9662563	3386220
Jun 07, 2017	2356893	Venture Debt	7715784	7022655	6461029	Hercules Capital
Jul 26, 2007	8331583	Venture Debt	2966099	8073809	5156278	5882096